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A B S T R A C T   
We coupled SPR imaging (SPRi) with matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) 
to identify new potential RNA binders. Here, we improve this powerful method, especially by optimizing the 
proteolytic digestion (type of reducing agent, its concentration, and incubation time), to work with complex 
mixtures, specifically a lysate of the rough mitochondrial fraction from yeast. The advantages of this hyphenated 
method compared to column-based or separate analyses are (i) rapid and direct visual readout from the SPRi 
array, (ii) possibility of high-throughput analysis of different interactions in parallel, (iii) high sensitivity, and 
(iv) no sample loss or contamination due to elution or micro-recovery procedures. The model system used is a 
catalytically active RNA (group IIB intron from Saccharomyces cerevisiae, Sc.ai5γ) and its cofactor Mss116. The 
protein supports the RNA folding process and thereby the subsequent excision of the intronic RNA from the 
coding part. Using the novel approach of coupling SPR with MALDI MS, we report the identification of potential 
RNA-binding proteins from a crude yeast mitochondrial lysate in a non-targeted approach. Our results show that 
proteins other than the well-known cofactor Mss116 interact with Sc.ai5γ (Dbp8, Prp8, Mrp13, and Cullin-3), 
suggesting that the intron folding and splicing are regulated by more than one cofactor in vivo.   
1. Introduction 
To identify molecular partners and simultaneously determine the 
binding affinity, a combination of several analytical methods would 
usually be required, rendering work laborious and time-consuming. The 
coupling of surface plasmon resonance imaging (SPRi) with mass spec-
trometry (MS) that was employed here combines quantitative analysis 
with unambiguous identification of captured target molecules in a single 
workflow [1–3]. SPRi allows to monitor binding affinities and kinetics in 
real-time and at very low amounts (femtomole range). SPR surfaces are 
reusable due to regeneration steps between different injections, which 
allow multiple measurements at different concentrations and, if neces-
sary, various conditions. To identify the molecules that were captured 
on an SPR surface, matrix-assisted laser desorption/ionization mass 
spectrometry (MALDI MS) and peptide mass fingerprinting were 
implemented. By performing SPR and MALDI MS separately, as usually 
done [4–6], the throughput and sensitivity would be seriously limited 
due to the need for target elution, which often leads to sample loss and 
contaminations. Therefore, performing MALDI MS measurements 
directly on the SPR chip is beneficial [7,8]. We have previously shown 
that the identity of interacting proteins not only from pure target solu-
tions but also from cellular lysates can be established [9]. The only other 
similar example reported is the study by Musso et al., which demon-
strated the detection of α-amylase from human saliva by 
antibody-arrayed SPRi surfaces [10]. To the best of our knowledge, 
screening for RNA binding proteins from cell lysates or specific com-
partments in e.g. mitochondria, with SPRi-MALDI MS has never been 
performed before. 
For unambiguous characterization of captured proteins, mass spectra 
of high quality are required. In the past, either self-digested peptides of 
trypsin dominated mass spectra and/or a small number of peptides were 
obtained from a single, purified injected protein [10–12]. Increasing the 
efficiency of on-chip proteolysis is therefore essential. To perform both 
analyses directly on the same surface, working with a MALDI MS 
compatible SPR chip surface is necessary. Thus, our study also includes 
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improved on-chip digestion, yielding a sufficient number of peptide 
peaks for confident classification. MS and MS/MS of low protein 
amounts in the fmol range from arrayed spots were obtained, resulting 
in increased protein identification reliability. 
For this study, we worked with the mitochondrial intron Sc.ai5γ from 
Saccharomyces cerevisiae (Sc.). It belongs to the class of group IIB introns, 
natural catalytic RNAs, which share mechanistic and structural simi-
larities with the spliceosome [13–15]. While in vitro self-splicing of 
group II introns can be initiated by high concentrations of divalent metal 
ions [16,17], in vivo the ribozyme functions presumably as a stable 
ribonucleoprotein (RNP). Structurally, group II introns are highly 
conserved and display six domains (DI – DVI) radiating from a central 
wheel [18]. Domain I (DI) is the largest domain, which contains essen-
tial binding sites for recognizing its exons and its natural protein 
cofactor - Mss116. 
Mss116 is a DEAD-box helicase and a member of a large ATP- 
dependent enzyme family involved in various aspects of RNA meta-
bolism [19,20]. Functionally, Mss116 acts not only as an on-pathway 
intermediate chaperon, preventing kinetic traps during the RNA 
folding process, but it is also involved in a number of other activities 
such as strand annealing, conformational switching, and charge 
neutralization [21–27]. Mss116, as the only natural identified cofactor 
for Sc.ai5γ maturation, is encoded in the nucleus and is transported to 
the mitochondrial matrix via a signal-peptide, where it can bind to group 
I and II intron RNAs and trigger their folding and subsequent splicing 
[22]. The mechanism of Mss116-mediated splicing includes resolving 
misfolded structures by RNA unwinding and stabilizing correctly folded 
on-pathway intermediates. Fedorova et al. showed that the protein 
directly stimulates the RNA folding in an ATP-independent manner. 
Still, ATP is required for the protein turnover - the dissociation from 
incorrectly formed complexes and rebinding unfolded RNA [25]. How-
ever, in vitro studies indicate incomplete splicing efficiency, which is in 
line with our hypothesis that other protein cofactors play a key role in 
the complete Sc.ai5γ maturation [23,28,29]. 
Although the interaction between Sc.ai5γ and Mss116 appears non- 
specific, the protein function, as an RNA cofactor, has been shown in 
the past by northern blotting [22]. Equilibrium binding assays by Halls 
et al. [30] demonstrated that Mss116 is able to interact with other 
classes of introns as well, namely group I and group II introns, with 
dissociation constants (KD) in the low nanomolar range, but the asso-
ciation and dissociation kinetic constants (kon and koff) were not deter-
mined. Mss116 is the only reported protein cofactor involved in Sc.ai5γ 
maturation, pre-mRNA splicing and ribosome assembly. However, the 
role of other mitochondrial proteins in Sc.ai5γ maturation remains un-
clear. While Mss116 was identified in a screening for nuclear mutants 
and their ability to grow in the presence or absence of introns [21], we 
demonstrate the ability of a hyphenated analytical method to discover 
other proteins that are supposed to be involved in the RNA binding 
process. With this, we successfully analyzed the lysate of a rough 
mitochondrial fraction from yeast and identified four previously un-
known potential Sc.ai5γ-interacting partners. 
2. Materials and methods 
2.1. Materials 
Trypsin Gold (mass spectrometry grade) was purchased from 
Promega. DNA linkers, oMGG03 and oMGG05, were ordered at IBA 
Lifesciences (Göttingen, Germany) and oMGG06 from Microsynth AG 
(Balgach, Switzerland). All sequences are given in the Supporting In-
formation. A. M. Pyle, Yale University, kindly provided plasmids pJD20 
and pHRH108. All chemicals were ordered at the highest available grade 
from Acros, Fluka, ABCR-Chemicals, or Merck. All solutions for SPR 
measurements were prepared using DNase, RNase, Protease free water 
(Molecular Biology Reagent, Sigma-Fine Chemicals). 
2.2. RNA preparation 
The group IIB intron Sc.ai5γ DNA, flanked by 41 nucleotides (nt) and 
14 nt long 5′- and 3′-exon respectively, was generated by polymerase 
chain reaction (PCR) amplification using the plasmid pJD20 as a tem-
plate [31,32], and primers oMGG01 and oSPA37, yielding finally 
plasmid pMGG01. The pMGG01 DNA construct was in vitro transcribed 
using an in-house produced T7 RNA polymerase. The RNA transcript 
(referred to as ex41-Sc.ai5γ-ex14 – superscript numbers indicate the 
number of nucleotides from the flanking exons) was purified on an 8% 
denaturing polyacrylamide gel, extracted by electroelution in 
Tris-borate-EDTA (TBE, pH 8.3) buffer, ethanol precipitated and finally 
dissolved in distilled water (adapted from Gallo et al.) [33]. 
2.3. Protein production 
The mitochondrial protein Mss116 (UniProt identifier P15424) DNA 
was derived from plasmid pHRH108 [34]. The full-length Mss116 DNA, 
lacking the mitochondrial localization sequence, was delivered in a 
commercially available pET-SUMO champion vector (Invitrogen), 
which contains an N-terminal His (6) tag, followed by a SUMO tag 
sequence. Protein expression and purification were performed as 
described [23,35], with the following modifications: The protein was 
expressed in BL21 cells. The bacterial cells were resuspended in a lysis 
buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 10 mM imidazole, 10% 
sucrose, 5 mM β-mercaptoethanol, 1% IGEPAL-630, and 10% glycerol). 
Cell lysis was performed by shock freeze in liquid nitrogen, thawing on 
ice, and sonication. The lysate was centrifuged at 20′000 g at 4 ◦C for 30 
min. The supernatant was filtered and purified by gravity flow Ni-NTA 
affinity chromatography. The chromatographic columns were filled 
with 2.5 mL Nickel-Chelating-Resin 50% slurry in 20% ethanol 
(G-Bioscience), washed with 10 column volumes of lysis buffer, and 
Nomenclature 
α-CHCA α-cyano 4-hydroxycinnamic acid 
ATP adenosine 5′-triphosphate 
BSA bovine serum albumin 
dH2O distilled water 
DNA desoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
FPLC fast protein liquid chromatography 
His histidine 
IGEPAL-630 detergent (registered trademark) 
nt nucleotide; 
MALDI MS matrix-assisted laser desorption/ionization mass 
spectrometry 
MOPS 3-(N-morpholino)propanesulfonic acid 
Ni-NTA nickel-nitrilotriacetic acid 
PCR polymerase chain reaction 
PMSF phenylmethylsulfonyl fluoride; 
RNA ribonucleic acid 
Sc Saccharomyces cerevisiae; 
SPRi surface plasmon resonance imaging 
SUMO Small Ubiquitin-like Modifier 
TBE Tris-borate-EDTA 
TCEP tris(2-carboxyethyl)phosphine; 
TFA trifluoroacetic acid 
Tris tris(hydroxymethyl)aminomethane  
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finally eluted in 2 mL fractions in a lysis buffer containing 250 mM 
imidazole. Mss116 protein was further purified by fast protein liquid 
chromatography (FPLC) Superdex 200 (GE Healthcare), the protein 
purity was checked by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS PAGE) (detailed results are in the Supporting In-
formation Fig. S1) and MS. Aliquots were stored at −20 ◦C in a storage 
buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM DL-dithiothreitol 
(DTT) and 10% glycerol). The protein activity was measured by an 
ATPase activity kit (Sigma-Aldrich) as described by the manufacturer. 
2.4. Preparation of rough mitochondrial fractions 
The protocol was adapted from Glick and Pon [36]. Harvested yeast 
cells were washed with water and collected by centrifugation at 4′000 g 
for 5 min at 25 ◦C. The pellet was resuspended in 100 mM Tris-HCl 
buffer (pH 8.4) and 10 mM DTT for 10 min at 30 ◦C and centrifuged 
at 2′000 g for 5 min at 25 ◦C. After washing with 1.2 M sorbitol and 
centrifuging for 5 min at 4′000 g at 25 ◦C, the pellet was resuspended in 
40 mL buffer containing 1.2 M sorbitol, 20 mM KH2PO4 (pH 7.4) and 3 
mg/g Zymolyase and incubating for 60 min at 30 ◦C in a water bath. All 
the subsequent procedures were performed at 0–4 ◦C. The suspension 
was centrifuged for 5 min at 2′000 g, the supernatant removed, and 100 
mL homogenization buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 0.2% BSA, 
1 mM PMSF, and 0.6 M sorbitol) was added to the pellet and mixed 
thoroughly. The suspension was homogenized using a Dounce homog-
enizer and then centrifuged for 5 min at 4′000 g. The supernatant was 
saved and additionally centrifuged for 12 min at 7′000 g. The resulting 
mitochondrial pellet was resuspended in 1 mL buffer containing 500 mM 
KCl, 80 mM MOPS (pH 6.9), 10 mM MgCl2, and 0.5% Triton-X. 
2.5. On-plate digestion optimization 
To improve the quality of the on-chip tryptic digestion of captured 
proteins after SPRi measurements, bovine serum albumin (BSA) was 
used in varying amounts (1 pmol, 100 fmol, and 10 fmol) as a control 
protein. To focus on the influences of added solutions and chemicals, 
BSA was spotted on a plate without extra immobilization. Furthermore, 
all steps were performed without explicitly mixing the solution on the 
plate. For reduction, DTT and Tris (2-carboxyethyl)phosphine hydro-
chloride (TCEP) were used at different concentrations (50 mM, 10 mM, 
5 mM, 1 mM, 0.5 mM, 0.1 mM and 0.01 mM in 25 mM NH4HCO3, pH 
8.5). 1 μL of the reducing agent was spotted on top of the BSA spots and 
allowed to react for 1 h, 40 min, 30 min, 20 min, or 10 min at 37 ◦C. For 
alkylation, 1 μL of iodoacetamide solution of varying concentrations (5 
mM, 1 mM, 0.5 mM, and 0.1 mM) was spotted and incubated for 1 h at 
25 ◦C in the dark. 1 μL of reducing agent was added with the same 
concentration as the used iodoacetamide (in 25 mM NH4HCO3 buffer, 
pH 8.5) to quench the excess of iodoacetamide. Subsequently, 1 μL of 
trypsin solution (5 ng/μL) was added to each spot and incubated at 37 ◦C 
for 10 min. Finally, the spots were dried at 37 ◦C, and the matrix solution 
(7 mg/mL α-Cyano-4-hydroxycinnamic acid (α-CHCA) in 50% acetoni-
trile/water with 0.3% trifluoroacetic acid (TFA)) was spotted. 
2.6. Surface plasmon resonance imaging 
All SPRi measurements were carried out using a commercial SPRi- 
Plex II instrument and standard gold SPRi slides for amine or biotin 
coupling, respectively (Horiba France, Palaiseau, France). RNA and BSA, 
as controls, were immobilized by spotting 0.3 μL (0.1 mg/mL) manually 
on the chip in a 4 x 4 spot array pattern. The blocking buffer consisted of 
1 M aqueous ethanolamine (pH 9.0) or 10 μg/mL biotin, respectively. 
For joining the SPRi slide with the surface of a glass prism with a high 
refractive index, a thin film of index-matching oil was used to connect 
both surfaces. SPRi experiments were performed at 25 ◦C with buffer 
containing 500 mM KCl, 80 mM 3-(N-morpholino)propanesulfonic acid 
(MOPS), pH 6.9, 10 mM MgCl2, and 10 μM ATP, respectively, with a flow 
rate of 50 μL/min and a 150 μL injection volume. For surface regener-
ation between measurements, 100 mM glycine hydrochloride 
(H2NCH2CO2H HCl, pH 2.0) was used. 
Measured kinetic curves were evaluated using the Scrubber Gen2 
software. For calculating the kinetic and binding constants kon, koff, and 
KD, a classical Langmuir model was applied. 
In preparation for the immobilization step, RNA was hybridized with 
short DNA linkers (oMGG03, oMGG05, or oMGG06) in distilled H2O in a 
1:1 ratio by heating for 3 min at 90 ◦C and then slowly cooling down to 
25 ◦C. 
2.7. MALDI MS 
For MALDI MS measurements, a tryptic digestion was performed 
directly on the chip surface after being removed from the SPRi instru-
ment and air-dried. The disulfide bonds of the target proteins were 
reduced for 1 h at 37 ◦C with 500 pmol of aqueous TCEP in 25 mM 
ammonium bicarbonate (NH4HCO3), pH 8.5. The addition of 25 mM 
NH4HCO3 solution prevents the sample from drying out. Trypsin (5 ng/ 
μL in 10 mM NH4HCO3, pH 8.3) was spotted (0.3 μL) onto the region of 
interest and kept in a humid atmosphere at 37 ◦C for 10 min. Finally, 
after the spots had dried and digestion had stopped, a MALDI matrix was 
applied (0.1 μL of 7 mg/mL α-CHCA in 50% acetonitrile/water with 
0.3% TFA). For MALDI MS measurements, the SPRi slide was mounted 
directly into a custom-made SPRi-MALDI adapter. Mass spectra were 
obtained with an Ultraflex II MALDI-TOF (Bruker Daltonics, Bremen, 
Germany), which is equipped with a "smartbeam” laser (337 nm UV 
laser based on a modified solid-state laser) working with a 66.7 Hz 
repetition rate, using the following parameter settings: positive ion 
reflectron mode, acceleration voltage: 25 kV, delayed extraction time: 
20 ns, laser fluence: just above the desorption/ionization threshold, 
number of laser shots: 1′500–2′500 (averaged and acquired at random 
sample positions). All mass spectra were smoothed, baseline-subtracted, 
and externally calibrated with a standard peptide calibration mix I 
(LaserBio Labs), which was also spotted onto the SPRi slide. Tryptic 
peptides were identified with the Biotools software (Bruker Daltonics) 
and Mascot software (Matrix Science Limited). 
3. Results and discussion 
3.1. Optimization of on-chip digestion 
In order to unambiguously identify proteins, on-chip proteolysis first 
needed to be improved. As previously described [9], we optimized the 
concentration of trypsin (5 ng/μL) as well as the incubation time (10 
min), salt concentration (10 mM NH4HCO3, pH 8.3), and temperature 
(37 ◦C). Because of the relatively small number of tryptic peptides 
generated (e.g. 8 peptides from a purified protein), which leads to a low 
sequence coverage (e.g. 12.3%) [9], we have further improved the 
on-chip proteolysis with BSA as a model protein. First, the influence of 
reduction prior to the addition of trypsin was studied. To the best of our 
knowledge, mainly two reagents are reported as reducing agents in 
tryptic digests, DTT and TCEP [37–40]. While keeping the reaction time 
constant, the concentration of the reducing agents was varied between 
0.01 and 50 mM. Optimal results were obtained at 0.5 mM for both 
reducing agents (Supplementary Table S2). Higher concentrations of 
reducing agents decreased the sensitivity, as many of the peptides 
detected at lower concentrations of reducing agent could no longer be 
observed. This observation indicates that high reducing agent concen-
trations have a strong suppressing effect. In addition, concentrations 
below 0.5 mM reduced the quality of the digest, with a substantial 
decrease in sequence coverage (e.g. from 62.1% to 27.5% for 100 fmol 
BSA with 0.5 mM and 0.1 mM TCEP, respectively) (Supplementary 
Table S2). The comparison between the peptide mass fingerprint anal-
ysis using DTT or TCEP, respectively, clearly shows that TCEP reacts 
significantly better (e.g. 68.0% sequence coverage for 100 fmol BSA) 
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than DTT (e.g. 24.7% sequence coverage for 100 fmol BSA) by a factor of 
more than two in sequence coverage (Fig. 1 A). Furthermore, compared 
to tryptic digestion without reduction, the reduction with TCEP doubles 
or even triples the sequence coverage, depending on the amount of 
protein (Fig. 1 A). It is noteworthy that we achieved a proteolytic digest 
of only 10 fmol BSA yielding 42.7% sequence coverage. Consequently, 
0.5 mM TCEP was chosen for all further experiments. 
Second, the influence of reduction over time was investigated. 
Minimizing the duration for reduction from 60 to 10 min induced a 
steady decrease in sequence coverage (Fig. 1 B). A reduction to 10 min 
resulted in a similar low sequence coverage as for the tryptic digestion 
without the reduction (between 10 and 25%). 
It is known that reduced disulfide bonds are often alkylated to pre-
vent the reformation of disulfide bonds and thus to refold [41]. There-
fore, we investigated whether an additional on-plate alkylation step 
further improves the coverage of the protein sequence. For this purpose, 
iodoacetamide was applied to increase the concentration from 0.1 to 5 
mM, while keeping reduction conditions, like temperature and duration 
time, constant (Fig. 1C). The use of this alkylation reagent has a similar 
impact on the digest as the reducing agents. The higher the concentra-
tion of iodoacetamide, the lower the sequence coverage, especially at 
lower BSA amounts. Low-intensity peaks are suppressed with higher 
concentrations of alkylation reagent. Overall, no new fragments were 
observed (Fig. 1 D and 1 E). Since no significant increase in sequence 
coverage was achieved by the addition of an alkylation step, but the 
experimental time almost doubled, alkylation was omitted in further 
experiments. These results show that we are able to overcome the dif-
ficulties of identifying proteins that occur in very small amounts, i.e. 100 
– 10 fmol, by peptide mass fingerprint analysis. 
3.2. Binding of ex41-Sc.ai5γ-ex14 to Mss116 
To date, only the affinity of Mss116 to Sc.ai5γ has been determined 
[30], but the binding and unbinding kinetics remain unknown. Initially, 
SPRi measurements were performed to characterize the association and 
dissociation rate constants (kon and koff) of Mss116 to the intact ex41-Sc. 
ai5γ-ex14. These constants give insight into how fast and specific the 
interaction between both molecules occurs and thus provide a better 
understanding of the biological system and exact mode of action. In a 
second step, we used SPRi-MALDI MS to identify additional 
RNA-binding proteins from a lysate of a rough mitochondrial fraction, 
which required improved on-chip proteolysis. 
To attach the RNA onto a surface, two different immobilization 
strategies were applied: a biotinylated DNA oligonucleotide was hy-
bridized either to domain IV (DIV) or to the 5′exon of ex41-Sc.ai5γ-ex14 
(Fig. 2 A). Hence, we examined whether the binding properties of 
Fig. 1. Comparison of sequence coverage from on- 
plate digested BSA (1 pmol, 100 fmol and 10 fmol) 
with varying conditions. (A) Tryptic digestion with 
and without reducing agent (0.5 mM TCEP and DTT, 
respectively, for 1 h). (B) Percentage of sequence 
coverage from tryptic digestion with reduced BSA 
(0.5 mM TCEP) at different time points. (C) Effect of 
the alkylation reagent iodoacetamide on the sequence 
coverage at different concentrations (w/o alkyl. =
without alkylation) after reduction (0.5 mM TCEP, 1 
h). (D) Mass spectra of reduced (0.5 mM TCEP, 1 h) 
and digested BSA (100 fmol) in the absence and the 
presence of alkylation agent (small inlet, 0.1 mM 
iodoacetamide). (E) Mass spectra of reduced (0.5 mM 
TCEP, 1 h) and digested BSA (100 fmol) in the pres-
ence of alkylation agent (0.1 mM iodoacetamide). 
Fragments are labeled with their sequence range in 
parentheses. Alkylated peptides are highlighted in 
blue. For clarity, not all identified peptides are 
labeled.   
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Mss116 to the RNA are influenced due to a structurally different 
conformation and accordingly identify the better preferable immobili-
zation position for an optimal interaction. Injections of Mss116 at 
various concentrations (5–135 nM) showed a slow dissociation, which 
does not reach the baseline level during the measuring time of 650 s 
(Fig. 2 B and Table 1). In agreement with previous investigations [34, 
42], the measured binding rates indicate a rapid binding of Mss116 
(with a fast association rate constant) and a prolonged release (Fig. 2 B 
and Table 1). 
Omitting ATP (10 μM) from the running buffer was found to have 
only little effects on the binding strength, with a KD value in the low 
nanomolar range (Table 1 and Fig. S2) as well as unaffected on- and off- 
rates. Variations in KD by a factor of 3–4 obtained from biophysical 
experiments are within the tolerance range. Our findings on the low 
impact of ATP are in good agreement with previous results, where it was 
shown that the presence of ATP has no influence on the protein-RNA 
binding strength [23]. In contrast, it was reported that the release of 
Mss116 from the RNA is ATP-dependent [25,43]. Therefore, the 
following experiments were performed in the presence of ATP. Never-
theless, we could not observe the complete dissociation of the protein 
from ex41-Sc.ai5γ-ex14, and under our experimental conditions, the 
protein remains bound to the target molecule. 
We tested two different immobilization approaches (DIV and 5′exon 
immobilization) to ensure that Mss116 binding is not hindered by the 
surface-immobilization, despite the binding site is believed to be in DI. 
The determined KD-values for both approaches are very similar and 
within the experimental error (Table 1, Figs. S2 and S3). No significant 
changes in the binding of Mss116 were observed when the biotin tag was 
replaced with an amine tag. The tag exchange was necessary for the DNA 
linker hybridizing to DIV and the target immobilization on a protein-free 
SPRi slide (Table 1 and Fig. S4). The results demonstrated that neither 
DIV nor the 5′exon is involved in Mss116 binding, and DI is not con-
cealed in both of the immobilization approaches, which is in line with 
previous findings that DI is the preferred counterpart for Mss116 [29]. 
Additionally, the measured binding rates indicate a rapid binding of 
Mss116 (with a fast association rate constant) and a prolonged release. 
3.3. SPRi-MALDI MS analysis of rough mitochondrial lysate from baker’s 
yeast 
Having shown that immobilization by either DIV or via the 5′exon 
does not affect Mss116 binding to ex41-Sc.ai5γ-ex14, we proceeded with 
SPRi-MALDI MS measurements and used the surface-immobilization via 
DIV. Although it is known that members of the DEAD-box helicases are 
often involved in multiple processes, such as mitochondrial intron 
splicing and transcription elongation [44], the interaction between Sc. 
ai5γ and other potential interactors has been poorly investigated. The 
hypothesis that group II introns and the spliceosome are evolutionarily 
related is well established. Following the theory of Galej and coauthors 
[45] that spliceosomal proteins gradually replaced intronic domains 
during the evolution from bacteria to eukaryotes, the presence of more 
than one cofactor for the mitochondrial group II intron is very likely. We 
assume that besides Mss116, other regulating factors participate in the 
splicing process of Sc.ai5γ. To support this hypothesis, we combined 
SPRi with MALDI mass spectrometry to screen and identify new po-
tential intron binders. This method allows also the detection of inter-
acting analytes in real time and the determination of association and 
dissociation constants. 
Firstly, on-chip tryptic proteolysis needed to be optimized (section 
3.1). Secondly, by performing SPRi-MALDI MS analysis, we faced 
another challenge. Although immobilization via biotin or amine tagged 
RNA resulted in only marginal differences in binding constants, it 
significantly affected the MALDI MS analysis. Biotinylated RNA is 
immobilized on SPRi slides coated with ExtrAvidin, a modification of 
avidin with high affinity and specificity to biotin. However, this caused 
too many disrupting, intense peaks in the mass spectrum (Fig. S5 A and 
B) coming from the ExtrAvidin protein coating when spots of interest are 
digested with trypsin. The replacement of the enzyme trypsin with 
AspN, to generate ExtrAvidin-peptides with higher m/z values did not 
improve the situation. In this case, autolysis products of AspN domi-
nated the entire mass spectrum (Fig. S5 C and D), even when the same 
low concentrations as for trypsin were used. Finally, to avoid interfering 
peaks, we used SPRi slides in the absence of any protein functionaliza-
tion. We chose N-hydroxy succinimide (NHS) ester functionalized sur-
faces, which require free amine groups on the molecule for 
immobilization. Obtaining high-quality mass spectra from on-chip pro-
teolysis of captured analytes (in the low fmolar range) from arrayed SPRi 
slides is considered challenging. By using our optimized workflow, after 
the immobilization of the amine-tagged ex41-Sc.ai5γ-ex14 (DIV), 
captured Mss116 could be identified after the injection of the pure 
protein, with a reasonably high number of fragments and a sequence 
coverage of 68% from only 9.4 fmol (Fig. 3 bottom and Fig. S6). 
To investigate if proteins other than Mss116 interact with ex41-Sc. 
ai5γ-ex14 we applied a rough mitochondrial lysate from yeast to the 
immobilized RNA. The MALDI MS experiment was performed after a 
Fig. 2. (A) Scheme of the secondary structure of ex41- 
Sc.ai5γ-ex14 indicating the proposed binding site for 
Mss116 (blue) at a central three-way junction (κ-ζ) 
within DI (orange). The different immobilization ap-
proaches via the 5′exon (left) and DIV (right) are 
shown. (B) SPRi measurement of the group IIB intron 
ex41-Sc.ai5γ-ex14 in the presence of ATP (10 μM) in 
running buffer and a concentration series of Mss116 
(5–135 nM). Calculated KD: 8.4 ± 0.7 nM (fits in 
grey). (For interpretation of the references to colour 
in this figure legend, the reader is referred to the Web 
version of this article.)   
Table 1 
Association (kon) and dissociation (koff) rate constants and KD of the interaction 
between ex41-Sc.ai5γ-ex14 and its cofactor Mss116 in the presence or the absence 
of ATP for both immobilization schemes (DIV and 5′exon). Standard deviations 
derive from two to four independent technical replicates.  
Immobilization tag and 
position 
ATP kon (M-1s-1) koff (s-1) KD (nM) 
biotin – DIV No (5.76 ± 0.07) 
x 104 




biotin –DIV Yes (1.20 ± 0.10) 
x 104 




biotin – 5′exon Yes (3.00 ± 0.10) 
x 104 




amine –DIV Yes (6.51 ± 0.05) 
x 104 
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single injection of the lysate and based on real-time detected plasmon 
curves, i.e. if an interaction is detected/not detected. The mass spectrum 
of the on-chip tryptically digested spots of interest revealed a high 
number of peptides (Fig. 3 top). A comparison between the peptide mass 
fingerprint spectrum of Mss116 (Fig. 3 bottom) and the mitochondrial 
fraction (Fig. 3 top) shows distinct differences, i.e. many peptides with 
different m/z values were observed, indicating that proteins other than 
Mss116 bind to ex41-Sc.ai5γ-ex14. Only three relatively low intensity 
peaks were observed, e.g. the signal at m/z 2055.841 (Fig. 3 top, zoomed 
part), indicating binding of Mss116. A Mascot database query of the 
fragments shows that several other proteins interact with the target RNA 
as well. Based on the peaks with a signal-to-noise ratio higher than 1.5 
and a mass deviation of less than 190 ppm (as achieved with on-chip 
digested Mss116), we identified four distinct proteins, namely the pre- 
mRNA-splicing factor 8 (Prp8), DEAD-box protein 8 (Dbp8), mito-
chondrial ribosomal protein 13 (Mrp13) and a protein known as Cullin- 
3. The identity of the last two proteins was further verified by MS/MS 
measurements of selected ions. The MS/MS spectrum of ion m/z 
1791.704 (Fig. 4) confirmed the amino acid sequence AKLDE-
FLIYHKTDAK originating from Mrp13. The fragmentation of the ion m/z 
2198.940 supports the presence of Cullin-3 (Fig. S7). 
To exclude non-specific adsorption resulting from the SPRi slide 
surface and thus false-positive signals, we used reference spots (without 
immobilized ex41-Sc.ai5γ-ex14) as controls. Here, no increasing signal in 
plasmon curves after adding the lysate or peptides from MALDI MS 
measurements was observed (data not shown). 
By screening a rough yeast mitochondrial lysate with SPRi-MALDI 
MS, we identified four new potential binders of the group II intron Sc. 
ai5γ, in addition to the well-known splicing cofactor Mss116. In the 
following section, we explain why these four proteins, namely Dpb8, 
Prp8, Mrp13, and Cullin-3, can bind to Sc.ai5γ. The ribosomal protein 
Dbp8 shares sequence similarities with Mss116, e.g., both are members 
of the DEAD-box family, named after the highly conserved amino-acid 
sequence D-E-A-D (asp-glu-ala-asp). This so-called Walker motif is 
required for ATP binding and hydrolysis. In addition, Dbp8 is an RNA 
helicase known to participate in synthesizing the small ribosomal sub-
unit (18S rRNA) and interacting with the target RNA via five conserved 
motifs (Ia, Ib, II, V, and VI) [46,47]. In contrast to Dbp8, the 
pre-mRNA-splicing factor 8 (Prp8) consists of domains analogous to the 
intron-encoded proteins (IEP), which assist in splicing [48]. Introns that 
lack such an IEP are supported by ATP-dependent helicases, like 
Mss116. Prp8 is part of the yeast spliceosome and the key regulator of 
intronic RNA splicing in the nucleus. The large domain of Prp8 interacts 
with both splice sites and the essential branch point by forming the 
catalytic core of the RNAP complex, very similar to the maturase domain 
in IEPs [45,49–51] Mrp13 is part of the small subunit of the mito-
chondrial ribosome, hence its name [52–54]. Cullin-3 is described as a 
scaffold protein involved in the degradation-related ubiquitylation 
pathway [55–57]. Similar to Mss116, both proteins carry hydrophilic 
residues that facilitate RNA binding. All four newly identified proteins 
comprise RNA-binding properties, either identical to Mss116 or to an 
IEP, that enable them to recognize RNA motifs present in Sc.ai5γ. Among 
these binders, Mrp13 is the only mitochondrial protein. The other three 
proteins are localized in the nucleus. The way these nuclear proteins can 
enter the mitochondria and whether they are localized remains unclear. 
The three nuclear proteins do not carry any signal peptide for the 
directed transport into the mitochondria. However, there are possible 
mechanisms known as ADP/ATP carrier via TIM22 complex, stress, or 
passive internalization to deliver cellular or nuclear proteins into 
mitochondria rather than the signaling peptide pathway [58,59]. It has 
been already shown that non-mitochondrial proteins and proteins 
derived from species different than yeast trigger the splicing in Sc.ai5γ in 
vitro [23]. Solem et al. demonstrated that the cytoplasmic 
ATP-dependent helicase DED1 and Cyt-19 in Neurospora crassa, both 
members of the DEAD-box family, stimulate Sc.ai5γ splicing in vitro. 
Suggestively, this is due to sequence and functional similarities to 
Mss116, and thus, these proteins bind similar RNA motifs. The here 
found RNA-binding proteins are known to be multifunctional, and 
therefore it is not surprising that they can bind different kinds of RNAs 
[30,60,61]. Similar to Mss116, which interacts with group I and II in-
trons, the identified proteins bind other RNAs and participate in one way 
or another in the RNA maturation process, as described in detail above. 
On the other side, group II introns are characterized by a complex sec-
ondary and tertiary structure highly conserved among all species. Sc. 
ai5γ comprises structural similarities with other intronic RNAs as well, 
and its cofactor Mss116 shares universal features with similar func-
tioning RNA-binding proteins [62]. It is possible that the proteins found 
bind the model-RNA based only on the sequence and structural simi-
larities, with respect to the RNA but also regarding the cofactors Mss116 
and IEP. Hence, the identification of four additional Sc.ai5γ binding 
candidates is a first experimental indication of other potential cofactors 
that may be involved in the group II intron splicing process in vivo. Their 
Table 2 
Captured and identified peptides after the injection of a rough mitochondrial fraction lysate and on-chip proteolysis using MALDI MS (compare Fig. 3 top). Peptides 
with their m/z value, number of missed cleavages (MC), signal-to-noise ratio (S/N), deviation from theoretical m/z (Δppm), and amino acid sequences are grouped into 
each identified protein resulting from a Mascot database request and peptide mass fingerprint.  
m/z MC S/N |Δppm| amino acid sequence protein 
1125.491 0 13 30.2 NYYYLFDK Prp8 (279.3 kDa) 
1475.688 1 27 140.2 SAIANTLLYLRLK 
1584.695 1 4 142.4 NDTKILVLALEDLK 
1687.934 0 32 72.5 WFLQHPDEEYPVK 
1828.810 1 5 139.3 GTIPLLERYIGNLITR 
2096.935 2 15 35.7 IINTHSDMASKMYNTDKK 
2236.929 2 10 122.7 YIGNLITRQFEGRSNEIVK 
2717.031 2 7 186.5 KYNVNISALTQTEIKDIILGQNIK 
3312.171 2 3 127.3 GILMASGSTTFTKVAAKWNTSLISLFTYFR 
3622.302 2 4 75.4 VAAKWNTSLISLFTYFREAIVATEPLLDILVK 
1339.568 0 10 144.1 IEYILVPEHVK Dbp8 (47.8 kDa) 
1797.801 2 9 34.1 ESLMAMQKENFGERK 
1818.776 2 7 119.5 TARAGRIGDAISFVTQR 
1947.881 2 11 79.6 AGRIGDAISFVTQRDVSR 
1791.704 2 33 145.2 AKLDEFLIYHKTDAK Mrp13 (38.9 kDa) 
2779.206 2 4 119.1 AIWTYISPIHVQKMLTASFFKIGK 
3223.205 0 4 145.1 QIGFTPELTGLQPVDISLPDIPNSSSGAELK 
1708.723 0 12 62.1 SQHSFLESIDFGSVR Cullin-3 (86.1 kDa) 
2051.868 2 23 151.7 LSLTPSILKRSIQLLIEK 
2091.865 2 12 109.1 SYINKNAINIPFNEGNRK 
2198.940 1 29 36.9 EGALPSEYLSTYVDHCMKR  
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presence in mitochondria and their biological relevance and interaction 
with Sc.ai5γ in vitro and in vivo needs further investigation. 
For further investigation, we applied epitope blocking to identify 
potential binding sites between the identified proteins and ex41-Sc.ai5γ- 
ex14,. Thereby, Mss116 was first injected to saturate its binding site on 
the RNA that was anchored on the SPR surface. Without regenerating the 
surface, the yeast mitochondrial lysate was subsequently added. The 
sensorgram signal increased only marginally compared to the direct 
injection of the mitochondrial fraction. The mass spectrum (Fig. 3 
middle) shows mainly peaks corresponding to Mss116 and only a few 
others that are different from those of mitochondrial lysate only (Fig. 3 
top). There are two possible explanations for this finding: (i) the newly 
identified binders share the same RNA binding site with Mss116, which 
cannot be removed because being present in large excess and the 
binding is not competitive, or (ii) binding of Mss116 to the RNA in-
troduces structural changes that prevent other proteins from binding to 
their target site, different from the Mss116 binding site. The latter case 
would imply that the other proteins possibly bind to the group II intron 
not in the pre-spliced state but rather at a later stage of the splicing 
reaction. To identify the exact binding regions, further experiments are 
required. By using different immobilization schemes of ex41-Sc.ai5γ- 
ex14, we could demonstrate that neither DIV nor the 5′exon is involved 
in Mss116 binding and that DI is accessible in each of the used immo-
bilization schemes. These results are consistent with the previously 
proposed Mss116 binding site in Sc.ai5γ, namely DI [29]. The obtained 
results demonstrate that the improved on-chip digestion workflow using 
SPRi-MALDI MS is a powerful tool for identifying new potential binders. 
4. Conclusions 
RNA-binding proteins are usually grouped into either specific or non- 
specific ones, where the latter is still poorly understood. How these 
proteins differentiate between binding sites is still unknown. A possible 
approach might be to investigate whether the binding is kinetically 
controlled. This would show differences in association and/or dissoci-
ation rate constants, while equilibrium dissociation constants (KD) may 
have similar values. The demand for screening and high-throughput 
analysis tools, including non-targeted approaches, is steadily 
increasing. The present RNA – protein interaction study demonstrates 
the potential of SPRi-MALDI MS as a general tool for identifying such 
interactions by using one of the largest known ribozymes (ex41-Sc.ai5γ- 
ex14) as a target. Non-targeted, non-covalent interactions are thereby 
also detected from a cell lysate, a complex mixture of proteins. For 
determining the identity of binding partners, a complementary 
Fig. 3. On-chip MALDI mass spectra after SPRi measurements and on-chip 
proteolysis (with reduction and trypsin as proteolysis enzyme) after (top) the 
direct injection of a rough mitochondrial fraction lysate, (middle) the injection 
of 250 nM Mss116 (causing saturation in the SPR sensorgram) and mitochon-
drial fraction without regeneration in between, and (bottom) the injection of 
Mss116 (135 nM). Grey bars mark the same peptides found in the spectra 
middle and bottom, while light red highlighted peptides were found in all three 
experiments. A complete assignment of the peptide mass fingerprint from 
Mss116 (bottom) can be found in Fig. S6 (Supporting Information). Assign-
ments of the peaks from the lysate (top) are given in Table 2. 
Fig. 4. SPRi-MALDI MS: On-chip MS/MS measurement of the peptide m/z 1791.704 (from Mrp13), which was detected after injecting a rough mitochondrial fraction 
lysate. A complete list with identified fragments (m/z values, cleavage site of the peptide (“ion”) and positions of involved amino acids, and the amino acid sequence) 
is given in the table to the right. 
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technique is adapted. Combining SPRi with MALDI MS in a unified 
workflow is a powerful tool for identifying target binders from specific 
cell compartments. So far, similar investigations have only been carried 
out on known protein-protein interactions [9,10]. The on-chip workflow 
developed here generates high-quality mass spectra (including better 
S/N values) and leads to enhanced confidence in protein identification. 
With the implementation of a reduction step prior to digestion and a 
proper amount of trypsin (see Materials and methods), we were able to 
overcome the difficulties of identifying marginal amounts of protein. 
The results show the first hits of a screening that has been conducted. 
While further studies will be needed to validate the function and binding 
strength of the identified proteins, we developed for the first time a 
screening method for potential RNA binders from a crude yeast extract 
using SPRi-MALDI MS. 
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